Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 5223 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
  Instructions 
  Search 
  IPS 
  My preferences 

 


This article has been cited by
1Factors Associated With High-Quality Guidelines for the Pharmacologic Management of Chronic Diseases in Primary Care
Caroline de Godoi Rezende Costa Molino,Nathalia Celini Leite-Santos,Franciele Cordeiro Gabriel,Sheila Kalb Wainberg,Luciana Pereira de Vasconcelos,Rafael Augusto Mantovani-Silva,Eliane Ribeiro,Nicolina Silvana Romano-Lieber,Airton Tetelbom Stein,Daniela Oliveira de Melo
JAMA Internal Medicine.2019;179(4)553
[DOI]
2Effects of CYP2C19*17 polymorphisms on the efficacy and safety of bromodigyrochlorophenylbenzodiazepine in patients with anxiety disorder and comorbid alcohol use disorder
Michael S. Zastrozhin,Anastasiya P. Antonenko,Elena V. Nesterenko,Leyla I. Seyfullaeva,Violetta R. Mustafina,Antonina P. Esakova,Elena A. Grishina,Alexandr S. Sorokin,Valentin Yu. Skryabin,Ludmila M. Savchenko,Evgeny A. Bryun,Dmitry A. Sychev
Drug Metabolism and Personalized Therapy.2018;33(4)187
[DOI]
3CYP3A subfamily activity affects the equilibrium concentration of Phenazepam® in patients with anxiety disorders and comorbid alcohol use disorder
Mikhail Sergeevich Zastrozhin,Valentin Yurievich Skryabin,Alexander Sergeevich Sorokin,Aleksey Evgenievich Petukhov,Valery Valerievich Smirnov,Ekaterina Petrovna Pankratenko,Elena Anatolievna Grishina,Kristina Anatolievna Ryzhikova,Aleksey Sergeevich Panov,Ludmila Mikhailovna Savchenko,Evgeny Alekseevich Bryun,Dmitry Alekseevich Sychev
Pharmacogenomics.2020;21(7)449
[DOI]